Robert I. Dowell

435 total citations
18 papers, 333 citations indexed

About

Robert I. Dowell is a scholar working on Organic Chemistry, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Robert I. Dowell has authored 18 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Molecular Biology. Recurrent topics in Robert I. Dowell's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Cancer Research and Treatments (4 papers) and Synthesis and Biological Evaluation (4 papers). Robert I. Dowell is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Cancer Research and Treatments (4 papers) and Synthesis and Biological Evaluation (4 papers). Robert I. Dowell collaborates with scholars based in United Kingdom and United States. Robert I. Dowell's co-authors include D C Blakey, RG Melton, Ion Niculescu‐Duvaz, Caroline J. Springer, P. J. Burke, D. Huw Davies, David Waterson, Philip N. Edwards, Stephen J. Foster and T. G. C. Bird and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Cancer and Tetrahedron Letters.

In The Last Decade

Robert I. Dowell

17 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert I. Dowell United Kingdom 9 179 118 88 48 46 18 333
Ruben G.G. Leenders Netherlands 13 250 1.4× 130 1.1× 51 0.6× 29 0.6× 46 1.0× 21 401
Shinsaku Nakagawa Japan 9 161 0.9× 53 0.4× 25 0.3× 28 0.6× 32 0.7× 31 312
Vesna Schauer-Vukašinović United States 11 242 1.4× 126 1.1× 35 0.4× 11 0.2× 45 1.0× 17 447
Pablo Cironi Spain 7 197 1.1× 211 1.8× 57 0.6× 13 0.3× 24 0.5× 13 375
Heather Ireland‐Zecchini United Kingdom 7 278 1.6× 214 1.8× 108 1.2× 10 0.2× 24 0.5× 7 347
Kengo Sumi Japan 10 451 2.5× 145 1.2× 72 0.8× 31 0.6× 7 0.2× 15 688
Ulrike Voigtmann Germany 11 213 1.2× 228 1.9× 194 2.2× 14 0.3× 9 0.2× 12 501
Nagarajan Chandramouli United States 9 297 1.7× 101 0.9× 52 0.6× 22 0.5× 6 0.1× 14 472
Laura K. Henchey United States 6 505 2.8× 260 2.2× 59 0.7× 14 0.3× 14 0.3× 7 599
Diane Maguire United States 6 175 1.0× 168 1.4× 31 0.4× 10 0.2× 29 0.6× 6 360

Countries citing papers authored by Robert I. Dowell

Since Specialization
Citations

This map shows the geographic impact of Robert I. Dowell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert I. Dowell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert I. Dowell more than expected).

Fields of papers citing papers by Robert I. Dowell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert I. Dowell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert I. Dowell. The network helps show where Robert I. Dowell may publish in the future.

Co-authorship network of co-authors of Robert I. Dowell

This figure shows the co-authorship network connecting the top 25 collaborators of Robert I. Dowell. A scholar is included among the top collaborators of Robert I. Dowell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert I. Dowell. Robert I. Dowell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Monks, Noel R., David C. Blakey, Robert I. Dowell, et al.. (2002). DNA interstrand cross-linking and TP53 status as determinants of tumour cell sensitivity in vitro to the antibody-directed enzyme prodrug therapy ZD2767. European Journal of Cancer. 38(11). 1543–1552. 21 indexed citations
2.
Blakey, D C, P. J. Burke, D. Huw Davies, et al.. (1997). ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumour regressions in colorectal tumour xenografts. European Journal of Cancer. 33. S39–S39. 6 indexed citations
3.
4.
Dowell, Robert I., Caroline J. Springer, D. Huw Davies, et al.. (1996). New Mustard Prodrugs for Antibody-Directed Enzyme Prodrug Therapy:  Alternatives to the Amide Link. Journal of Medicinal Chemistry. 39(5). 1100–1105. 28 indexed citations
5.
Blakey, D C, P. J. Burke, D. Huw Davies, et al.. (1996). ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal tumor xenografts.. PubMed. 56(14). 3287–92. 44 indexed citations
6.
Springer, Caroline J., Robert I. Dowell, P. J. Burke, et al.. (1995). Optimization of Alkylating Agent Prodrugs Derived from Phenol and Aniline Mustards: A New Clinical Candidate Prodrug (ZD2767) for Antibody-Directed Enzyme Prodrug Therapy. Journal of Medicinal Chemistry. 38(26). 5051–5065. 64 indexed citations
7.
Niculescu‐Duvaz, Ion, Robert I. Dowell, D. Huw Davies, et al.. (1995). A new clinical candidate for antibody-directed enzyme prodrug therapy (ADEPT): ZD2767. Journal of Cancer Research and Clinical Oncology. 121(S1). A7–A7. 1 indexed citations
8.
Blakey, D C, Philip J. Burke, D. Huw Davies, et al.. (1995). Antibody-directed enzyme prodrug therapy (ADEPT) for treatment of major solid tumour disease. Biochemical Society Transactions. 23(4). 1047–1050. 11 indexed citations
9.
Burke, Patrick, et al.. (1994). Tumour regressions with novel prodrugs in antibody-directed enzyme prodrug therapy (ADEPT). European Journal of Cancer. 30. S9–S9. 1 indexed citations
10.
Dowell, Robert I., et al.. (1993). 4-Methoxy-2-methyltetrahydropyrans: chiral leukotriene biosynthesis inhibitors, related to ICI D2138, which display enantioselectivity. Journal of Medicinal Chemistry. 36(2). 295–296. 11 indexed citations
11.
Bird, T. G. C., Pierrick Bruneau, Robert I. Dowell, et al.. (1993). Structure and activity relationships leading to the discovery of ICI D2138, a selective, potent and orally active inhibitor of 5-lipoxygenase.. PubMed. 6(1-3). 249–57. 6 indexed citations
12.
Dowell, Robert I., Philip N. Edwards, Stephen J. Foster, et al.. (1992). Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors. Journal of Medicinal Chemistry. 35(14). 2600–2609. 69 indexed citations
13.
Dowell, Robert I., et al.. (1992). Novel inhibitors of prolyl 4-hydroxylase. Journal of Medicinal Chemistry. 35(5). 800–804. 37 indexed citations
14.
Dowell, Robert I., Philip N. Edwards, Stephen J. Foster, et al.. (1992). ChemInform Abstract: Methoxytetrahydropyrans. A New Series of Selective and Orally Potent 5‐ Lipoxygenase Inhibitors.. ChemInform. 23(51). 7 indexed citations
15.
Dowell, Robert I., et al.. (1982). The reversible cation-anion isomerisation of 2-imino-2H-pyrido [1,2-b][1,2,4]thia(oxa)diazole hydrobromide. Tetrahedron Letters. 23(4). 485–488. 6 indexed citations
16.
Bowler, Jean, et al.. (1975). The synthesis and biological activity of alkyloxy prostaglandin analogues. Prostaglandins. 9(3). 391–396. 4 indexed citations
17.
Dowell, Robert I., et al.. (1971). Seco-steroids. Part III. 5,6-Secoprogesterone. Journal of the Chemical Society C Organic. 2499–2499.
18.
Dowell, Robert I., et al.. (1971). Seco-steroids. Part II. 9,11-Secoprogesterone. Journal of the Chemical Society C Organic. 13. 2496–2496. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruben G.G. Leenders Breakdown of academic impact, for papers by Shinsaku Nakagawa Breakdown of academic impact, for papers by Vesna Schauer-Vukašinović Breakdown of academic impact, for papers by Pablo Cironi Breakdown of academic impact, for papers by Heather Ireland‐Zecchini Breakdown of academic impact, for papers by Kengo Sumi Breakdown of academic impact, for papers by Ulrike Voigtmann Breakdown of academic impact, for papers by Nagarajan Chandramouli Breakdown of academic impact, for papers by Laura K. Henchey Breakdown of academic impact, for papers by Diane Maguire
Rankless by CCL
2026